Market Exclusive

Analyst Upgrades – Aratana Therapeutics (NASDAQ:PETX) Stock Gets Upgraded By CL King from Buy to

Analyst Ratings For Aratana Therapeutics (NASDAQ:PETX)

Today, Aratana Therapeutics (NASDAQ:PETX) stock received an upgrade by CL King from Buy with a price target of $8.00.

Some recent analyst ratings include

Recent Insider Trading Activity For Aratana Therapeutics (NASDAQ:PETX)
Aratana Therapeutics (NASDAQ:PETX) has insider ownership of 5.20% and institutional ownership of 71.07%.

Recent Trading Activity for Aratana Therapeutics (NASDAQ:PETX)
Shares of Aratana Therapeutics closed the previous trading session at 4.39 up +0.13 3.05% with 4.320000171661377 shares trading hands.

Exit mobile version